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ABSTRACT The opening of the Alzheimer’s Ab channel permits the ﬂux of calcium into the cell, thus critically disturbing
intracellular ion homeostasis. Peptide segments that include the characteristic histidine (His) diad, His13 andHis14, efﬁciently block
theAb channel activity, blockingAb cytotoxicity.Wehypothesize that the vicinal His-His peptides coordinatewith the rings of His in
the mouth of the pore, thus blocking the ﬂow of calcium ions through the channel, with consequent blocking of Ab cytotoxicity. To
test this hypothesis, we studied Ab ion channel activity and cytotoxicity after the addition of compounds that are known to have His
association capacity, such as Ni21, imidazole, His, and a series of His-related compounds. All compounds were effective at
blockingbothAb channel andpreventingAb cytotoxicity. Theefﬁciencyof protectionofHis-related compoundswascorrelatedwith
the number of imidazole side chains in the blocker compounds. These data reinforce the premise that His residues within the Ab
channel sequence are in the pathway of ion ﬂow. Additionally, the data conﬁrm the contribution of the Ab channel to the cytotoxicity
of exogenous Ab.
INTRODUCTION
A consensus on the primary mechanisms that cause neuronal
damage in Alzheimer’s disease (AD) remains elusive, but
numerous reports have associated the cytotoxicity of amyloid
beta peptides (Ab) with the neurodegeneration observed in
speciﬁc brain areas of AD patients (1–4). It has been shown
that addition of fresh aggregates of Ab to cell cultures gen-
erates a potentially toxic increase in the intracellular calcium
concentration (5–9). Years of research supports the concept
that disturbances of intracellular calcium homeostasis may
play a pathological role in the neurodegeneration associated
with AD (10–13).
A mechanism for the Ab peptide-induced increase in in-
tracellular calcium was originally proposed based on the
formation of an independent tromethamine and aluminum-
sensitive Ab channel (14). This Ab channel, which permits
the entrance of extracellular calcium ions into the cell (15,16),
has been conﬁrmed in a variety of membranes by many re-
searchers over the past decade (17–22), has been observed
with atomic force microscopy (AFM) (23,24), and has been
subjected to theoretical modeling (25–27). The asymmetry in
one of the models (25) explains our ﬁnding that zinc prefer-
entially binds and blocks only one side of theAb channel (28).
It has been frequently demonstrated in studies of different
metalloproteases, as well as in the Abmolecule, that sites rich
in histidine (His) and anionic residues are associated with
Zn21 binding (29–33). Because of the unique chemical nature
of the His residue, it has a strong metal afﬁnity. His residues
act as a ligand to ametal center (34) bridging imidazole groups
from the side chains of His residues (33). In the theoretical
models of Durell et al. (25), the least energy calculations for
the full size Ab channels, imbedded in a lipid environment,
position the rings of His13 and His14 of the Ab molecule
around the entrance of the putative pore. To test this prediction
for the modeling algorithm, we recently showed that peptide
segments that copy sectors of the sequence of the Ab mole-
cule containing the two neighboring His13 and His14 residues
effectively block Ab channel activity in planar lipid bilayers
(16,35,36).When theHis-His diad is substitutedwith residues
that lack a propensity to interact with His residues, the pep-
tides lose their effectiveness to both block the Ab channel and
prevent Ab peptide cytotoxicity (36). Furthermore, methyl-
ation of the imidazole side chains of His residues in the Ab
peptide prevents the formation of His bridges, and also results
in abolition of Ab peptide neurotoxicity (37). We have in-
terpreted these data to indicate that the blocker peptides
containing the His-His diad form conventional coordination
complexes with complementaryHis-His diads in the other Ab
subunits of the Ab channel. Disruption of these complexes by
the His-His diadic peptide segments prevents the formation
of the potentially toxic Ab channels. Therefore, we now
hypothesize that compounds that are known to have His co-
ordinating capacity, such as Ni21, imidazole, His, and His-
related compounds should interfere with the currents and
cytotoxicity of Ab channels. We report here that the hy-
pothesis is supported by the experimental data. We found that
His-coordinating and His-related compounds can efﬁciently
block Ab channels incorporated in artiﬁcial membranes, and
can also entirely prevent Ab cytotoxicity. Therefore, we
believe that these results reinforce the concept that the toxicity
of the Ab peptide on cells is basically exerted through the
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capacity of Ab peptide to form Ab ion channels in the cell
surface membrane.
MATERIALS AND METHODS
Planar lipid bilayer methodology
A suspension of palmitoyloleoyl phosphatidylserine and palmitoyloleoyl
phosphatidylethanolamine (Avanti, Alabaster, AL), 1:1, in n-decane was
prepared. This suspension was applied to an oriﬁce of ;100–120 mm di-
ameter with a Teﬂon ﬁlm separating two compartments, 1.2mL volume each.
The ionic solutions in the compartments contained asymmetrical concen-
trations of CsCl (200 cis/50 trans mM) and symmetrical 0.5 mM CaCl2 and
5 mM K-HEPES, pH 7. The two ionic compartments were electrically con-
nected to the input of a voltage clamp ampliﬁer. Current was recorded using a
patch clamp ampliﬁer and data were stored on computer disk memory.
Ofﬂine analysis of the channel activity was carried out using the software
package pClamp (Axon Instruments, Foster City, CA). Incorporation of Ab
peptide into the bilayer was obtained by adding an aliquot of proteoliposome
(Ab-liposome) suspension to the solution in the cis side of the planar lipid
bilayer chamber and stirring.
Preparation of proteoliposomes
Liposomes were prepared by hydration of air-dried palmitoyloleoyl
phosphatidylserine (10 mg) with 1 M potassium aspartate, pH 7.0 (1 mL),
followed by water sonication for 5 min. The liposome suspension (50 mL)
was mixed with a stock aqueous solution of Ab peptide (1 mg/mL, obtained
from Bachem, Torrance, CA, and AnaSpec, San Jose, CA), followed by
sonication.
Materials and His-related compounds
NiCl2, imidazole, and L-His were purchased from Sigma-Aldrich (St. Louis,
MO). The His-related compounds NAHIS01 (Ac–His–CONH2), NAHIS02
(Ac–His–His–CONH2), and NAHIS04 (Ac–His–His–His–His–CONH2),
which contains one, two, and four His residues, respectively, were synthe-
sized as amide and capped in the amino terminal with acetic anhydride.
NAHIS02-(p-Met) (Ac–His-p-Met–His-p-Met–CONH2) was synthesized
combining Fmoc-His(3-Me)-OH (Fmoc-His(p-Me)-OH; Bachem), which
possesses the imidazole group methylated at the p position.
Cell culture
PC12 cells, derived from a transplantable rat pheochromocytoma (ATCC
No. CRL 1721), were cultured in the recommended ATCCmedium. Primary
cultures of hippocampal and cortical neurons from P18-P21 rat brains were
grown in neurobasal medium/B27 (GIBCO, Carlsbad, CA). For neuron
preparation, pregnant rats were anesthetized and killed to extract the fetuses.
For pain alleviation, the animals were anesthetized following recommen-
dations in the 2000 Report of the American Veterinary Medical Association
Panel on Euthanasia. Brains from the fetuses were dissected out and neuronal
cell cultures were prepared as in a previously described protocol (9).
Cell viability assays
The percentage of cells protected from Ab-induced cell death by various
treatments was evaluated by means of a colorimetric XTT assay (Cell Pro-
liferation Kit II, Roche, Mannheim, Germany). The cytotoxicity was also
directly measured by the release of lactate dehydrogenase (LDH) from the
cytosol into the media (Cytotoxicity Detection Kit (LDH), Roche).
RESULTS
Effect of Ni21 and imidazole on the Ab ion
channel electrical activity
Based on the theoretical model proposed by Durell et al. (25),
the predicted pore region of the Ab channel is made of the
hydrophilic structure composed of residues 1–16. The
structure formed by a radial polymer of four to six Ab sub-
units predicts that rings of His residues surround and form the
path for the ions passing through the pore. The results from
our previous work (36,37) show that the common feature of
the active Ab channel blocker peptides is that they all possess
in their sequence the two vicinal His residues that have been
modeled as lining the entry to the pore. It is therefore possible
that compounds of known His coordinating capacity will
interact with His in the mouth of the pore. This interaction
will block the entrance to the Ab pore, and consequently
affect the ﬂow of current through the Ab channel. We studied
various compounds of known His coordinating capacity for
their interaction with Ab channels incorporated into planar
lipid bilayers. No membrane potential difference was applied
to the lipid bilayers, to avoid any disturbing effect the
membrane potential might have on the channel activity and
the conformations of the channel. The experiments depicted
in Fig. 1 A show that when incorporated into a lipid bilayer,
the Ab channel operates between multiple conductance
levels. One channel is responsible for the multiple conduc-
tance levels and each channel incorporation may show a
different pattern of conductance transitions, as has been de-
scribed elsewhere (14,35). The insert in Fig. 1 A shows that
discrete jumps of current to different levels (1.46, 2.92, 5.03,
and 10.17 pA) can be observed throughout. The addition of
Ni21, which coordinates with imidazole with high afﬁnity,
and imidazole, which has a preference to have an interplanar
interaction with other aromatic residues, blocks the current
activity of Ab channels incorporated in lipid bilayers. After
the ionic current through the incorporated Ab channels ap-
peared stable for several minutes, either Ni21 or imidazole
was added to the experimental chamber. The current records
in the ﬁgure display 8 s of activity from the Ab channels,
maintained at zero membrane potential, before (control) and
several seconds after the channels were exposed to either
Ni21 (Fig. 1 A) or imidazole (Fig. 1 C). The channel activity
slowly reduced to an undetectable level, suggesting a full
block of the channel. The blockage by both Ni21 (not shown)
and imidazole (bottom record of Fig. 1 C) was irreversible
since the channels remained fully blocked after the chamber
was washed. Amplitude histograms of the current events
during same time intervals of channel activity before and at
different times after the addition of the test compounds were
elaborated and are displayed in the right panels of Fig. 1, B
and D. The histograms show that both Ni21 and imidazole
are effective at quickly abolishing the number of observa-
tions of the most frequent peak current values (0.8, 3.2, 5.2,
7.5, and 10 pA).
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Effect of His on the Ab ion channel
electrical activity
We have previously shown that His residues are essential
components in the sequence of active Ab ion channel blocker
peptides (36,37). His is an aromatic amino acid that contains
a heteroaromatic imidazole ring available for interaction. To
study the contribution of the imidazole ring in the His in-
teraction with the Ab ion channel, we investigated the
channel blocking efﬁciency of a modiﬁed, end-capped His
(NAHIS01) and compared it with the blocking efﬁciency of
the unmodiﬁed, amino and carboxyl ends-free His. The end-
capped His, with the carboxyl and amine group amidated and
acetylated, respectively, would leave the imidazole side chain
as the sole group available for interaction with other reactive
groups in the Ab channel.
The current activity from Ab channels illustrated in
Fig. 2 indicates that both unmodiﬁed His and modiﬁed His
NAHIS01 affect the peaks of ionic current from anAb channel
incorporated in a lipid bilayer. The current records in Fig. 2, A
and C, and the current amplitude histograms in the Fig. 2, B
and D, show that unmodiﬁed His mildly reduces the Ab
channel activity and is relatively ineffective at producing an
irreversible full block of the Ab channels. The peaks of ionic
current corresponding to larger channel conductance (5.8 and
4.2 pA) are blocked in a concentration-dependent manner, but
the smaller current peaks remain unaffected at the highest
concentration of His. As shown in Fig. 2, C and D, although
the modiﬁed His NAHIS01 failed as a full channel blocker, it
more effectively reduced the Ab channel activity at lower
concentrations.
The Ab channel blocking efﬁciency of His-related
compounds increases with the number of
imidazole side chains
In the previous experiments we showed that NAHIS01, in
which the imidazole is the sole group available for interac-
tion, is very efﬁcient at blocking the Ab ion channel. Here we
studied the ability of two His-related compounds, NAHIS02
and NAHIS04, to block Ab channels. These compounds
possess two and four imidazole side chains, respectively. The
current records and current amplitude histograms from Ab
FIGURE 1 Nickel and imidazole ir-
reversibly block the membrane-bound
Ab ion channel. (A and C) Electrical
activity across a lipid bilayer with in-
corporated Ab channels, recorded be-
fore (control) and in the presence of
either Ni21 (A) or imidazole (C). The
membrane electrical potential in the ex-
periment was maintained at zero level.
B and D display the current amplitude
histograms of the channel activity from
the current traces in A and C. Five main
current peaks of 0.8, 3.2, 5.2, 7.5, and 10
pA characterize the Ab channel activity.
Both compounds quickly abolish the
most frequent current peaks.
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channels, before and after exposure to the two His-related
compounds, are illustrated in Fig. 3. During the current re-
cording the bilayer was maintained at zero membrane po-
tential. The current records in Fig. 3, A and C, show that both
compounds efﬁciently block the multiple conductances ex-
hibited by the Ab channels. However, one of the distin-
guished observations is an apparent higher afﬁnity by
NAHIS04 for the channel that stayed fully blocked after the
chamber was washed. The lower current record in Fig. 3 C
shows that NAHIS04, which possesses four imidazole side
chains, is the most effective at irreversibly blocking the Ab
channel activity. The lower current record in Fig. 3 A shows
some recovery of channel activity after NAHIS02 was
washed off. No effect of membrane potential in the blocking
capacity of these compounds was observed (not shown). We
previously reported that the level of the membrane potential
has no effect on the ability of similar His-related compounds
to block the Ab channel (35). The current amplitude histo-
grams in Fig. 3, B and D, show a gradual reduction in the
number of current peaks after the Ab channels are exposed to
either one of these His-related compounds. The results reveal
that the number of imidazole side chains in the blocker
compounds has a substantial inﬂuence on their efﬁciency for
blocking the Ab channel conductance. The experiment il-
lustrated in Fig. 3C shows that NAHIS04 (16.66 mM), which
possesses four imidazole side chains, reduced the Ab channel
activity to occasional channel openings just 20 s after addi-
tion. By contrast, at the same concentration, NAHIS02,
which possesses two imidazole groups, takes several minutes
to produce similar levels of channel blockage.
The contribution of the imidazole side chains in the His-
related compounds to block the Ab channel activity was
veriﬁed with the experiments shown in Fig. 4. Here the ef-
fectiveness of the His-coordinating and His-related com-
pounds was studied in terms of the time required to block the
Ab channel currents. The top current record in Fig. 4 A
displays the time course of the Ab channel activity before and
after the addition of the channel blocker NAHIS02. The
bottom current record displays the channel activity from a
similar experiment in which increasing concentrations of
FIGURE 2 Efﬁcacy of His to block
the Ab channel is improved by capping
its amino and carboxyl ends. (A and C)
Electrical activity from two lipid bilay-
ers with incorporated Ab channels, re-
corded before (control) and while the
Ab channel was exposed to various
concentrations of unmodiﬁed, amino
and carboxyl ends-free His, and a mod-
iﬁed His, NAHIS01, with the carboxyl
and amine groups amidated and acety-
lated. The Ab channels were exposed to
each concentration of the blocker com-
pounds for 2-min periods. Increases in
the concentration of the unmodiﬁed His
only affect the current peaks of 5.8 and
4.2 pA, corresponding to larger channel
conductance. NAHIS01 is more effec-
tive at reducing all current peaks at
much lower concentrations than unmod-
iﬁed His. B and D display the amplitude
distribution histograms of the ionic cur-
rent peaks recorded while the Ab chan-
nel was exposed to each concentration
of His and NAHIS01, respectively.
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a modiﬁed NAHIS02, NAHIS02-(p-Met), were added.
NAHIS02-(p-Met) is a modiﬁed NAHIS02 in which the imid-
azole side chains are methylated. The unmodiﬁed NAHIS02, at
16.66 mM, totally blocks the Ab channel activity in,3 min.
In contrast, NAHIS02-(p-Met) is unable to block the Ab
channel activity even at a fourfold higher concentration, in-
dicating that the methylation of the imidazole groups reduces
the afﬁnity of NAHIS02 for the Ab molecule and conse-
quently the ability to block the Ab channel. When Ab chan-
nels are incorporated into artiﬁcial membranes, they form
multiconductance systems. This is manifested by frequently
ﬂuctuating conductance between speciﬁc levels. To com-
paratively evaluate the blocking strength of the test com-
pounds in terms of the time required to stop the Ab channel
activity, experiments similar to that displayed in Fig. 4 A
were performed with each one of the test compounds. The
results were analyzed by an alternative procedure that
quantiﬁes the total ionic current ﬂowing through the Ab
channel incorporated into the artiﬁcial lipid membrane at any
given time. For this purpose, we integrated the total ionic
current ﬂowing through the membrane and averaged the
amount of charge conducted in consecutive time intervals of
8 ms duration. The integration was initiated after the incor-
porated channel achieved stable activity, and also after the
addition of the test compounds. The left panel plot in Fig. 4 B
shows that imidazole is extremely efﬁcient at promptly (30 s)
blocking the ﬂow of ionic charges, in contrast to His, which
was very slow-acting or had almost no channel-blocking
capacity. Ni21 ions, as also shown in Fig. 2 A, fully blocked
the Ab channel within a few seconds (120 s). The plot in the
right panel in Fig. 4 B shows that the efﬁciency for stopping
the Ab channel activity of the His-related compounds ap-
FIGURE 3 Ab channel blocking efﬁ-
ciency of His-related compounds in-
creases with the number of imidazole
side chains. (A and C) Electrical activity
from two lipid bilayerswith incorporated
Ab channels, recorded before (control)
and while the Ab channels were exposed
to two compounds that possess two
(NAHIS02) and four (NAHIS04) imida-
zole side chains, respectively. The cur-
rent records show the channel activity at
various times after the channels were
exposed to two concentrations of the
blocker compounds. After full blockage
of the Ab channel, the blocking action of
NAHIS02 reversed when the experimen-
tal chamber was washed of the blocker.
The blockage by NAHIS04was irrevers-
ible. B and D display the amplitude dis-
tribution histograms of the ionic current
peaks recorded while the Ab channel
was exposed to various concentrations of
NAHIS02 and NAHIS04, respectively.
At a concentration of 16.66 mM both
compounds removed all current peaks.
However,NAHIS04producedfullblock-
age more quickly.
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pears to increase as the number of imidazole side chains in the
His-related compound is increased. Hence NAHIS04, which
has four imidazole side chains, reduces the ﬂow of ionic
charges through the membrane by 50% in 15 s. This reducing
effect is eightfold faster compared to the 125 s it takes for
NAHIS02, which has two imidazole side chains, to achieve
the same level of reduction. In contrast, NAHIS01, which
only has one imidazole side chain, does not fully prevent the
ﬂow of ionic charges, and NAHIS02-(p-Met), from which
imidazole reactivity is removed by methylation, showed no
blocking capacity.
Protection of cells from the Ab cytotoxicity
increases in efﬁciency with the number of
imidazole groups in the Ab channel blocker
We have previously shown that Ab cytotoxicity can be
prevented when cells are incubated in media containing Ab
channel blockers (9,16,37). Since Ni21, imidazole, His, and
His-related compounds affect, to different degrees, Ab
channels incorporated into artiﬁcial membranes, we exam-
ined the ability and relative strength of these compounds to
protect cells from Ab peptide-induced cell death. Cell via-
bility was examined using two different assays. These were
the colorimetric XTT assay that quantiﬁes metabolically
active cells, and an assay that measures the release of LDH
from the cytosol into the media, which evaluates the cell
membrane integrity. The panels in Fig. 5 show the viability of
PC12 cells (A and B), and cortical (C and D) and hippo-
campal neurons (E and F) observed after 3 days of incubation
in the presence of Ab peptide (5mM) and Ab peptide (5 mM)
plus Ni21, imidazole, or His. The left panels (A, C, and E)
show the results from the XTT assay expressed as a per-
centage of cytotoxicity, and the right panels (B, D, and F)
show the results from the measurements of LDH released
from cells into the media expressed as a percentage of pro-
tection of cells. The performance of imidazole, Ni21, and His
to maintain cell viability and protect cells from Ab peptide-
induced cell death strongly corresponds to what one would
expect from their effects displayed on the ionic current
ﬂowing through the Ab channels incorporated into artiﬁcial
membranes. Imidazole and Ni21 were found to fully protect
the cells against Ab cytotoxicity, but Ni21 showed a cell-
dependent toxicity at high concentrations. On the other hand,
His, which mildly reduced the Ab channel activity, per-
formed poorly in protecting cells from Ab toxicity. The
panels in Fig. 6 show the viability of PC12 cells (A and B),
and cortical (C and D) and hippocampal neurons (E and F)
observed after 3 days of incubation in the presence of Ab
peptide (5 mM) and Ab peptide (5 mM) plus the His-related
FIGURE 4 Time course of ionic
charge conducted by membrane-incor-
porated Ab channels, showing the effect
of Ab channel blockers. (A) The current
records show the time course of the
activity of Ab channels incorporated
into planar lipid bilayers before and after
the addition of the Ab channel blocker
NAHIS02 (top record) and NAHIS02-
(p-Met) (bottom record). The concentra-
tion of NAHIS02-(p-Met) was gradually
increased as indicated, at the times sig-
naled by the arrows. NAHIS02-(p-Met)
did not affect the Ab channel activity
even at a fourfold higher concentration.
(B) The amount of charge conducted by
bilayer-incorporated Ab channels before
and after the addition of imidazole, Ni21,
and His at concentrations of 41.5 mM
(left plot), and NAHIS01, NAHIS02,
NAHIS02-(p-Met), and NAHIS04 at a
concentration of 16.6 mM (right plot).
The ionic current ﬂowing through the
membrane was integrated in consecutive
time intervals of 8-ms duration. The efﬁ-
ciency to stop Ab channel activity in-
creases as the number of imidazole side
chains in the blocker compounds is in-
creased. pC: picoCoulombs.
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compounds NAHIS01, NAHIS02, NAHIS02-(p-Met), or
NAHIS04. The left panels (A,C, and E) show the results from
the XTT assay as a percentage of cytotoxicity, and the right
panels (B, D, and F) show the results from the measurements
of LDH release into the media as a percentage of protection of
cells. The performance of the His-related compounds to
protect cells from the Ab peptide-induced cell death also
strongly corresponded to what one would expect from their
effects displayed on the ionic current ﬂowing through the Ab
channels incorporated into artiﬁcial membranes. NAHIS02
and NAHIS04 fully protected the three different types of cells
against Ab. NAHIS01, which did not fully block Ab chan-
nels in artiﬁcial membranes (see Fig. 3), showed partial
protection. The level of protection for all these compounds
correlated with the number of imidazole side chains in these
compounds. For instance, the concentration required for 50%
protection (half maximal effective concentration, EC50) for
the three different types of cells for the compounds NAHIS02
and NAHIS04 was always below 1 mM. The EC50 for im-
idazole was between 2 and 3 mM (see Fig. 6). The compound
NAHIS02-(p-Met) was very inefﬁcient at protecting against
Ab peptide cytotoxicity. The mild protection observed with
this compound was cell-type dependent and always plateaued
at much higher concentrations than that observed with the
unmethylated form. Full methylation of NAHIS02-(p-Met)
is never achieved during the synthesis process. Therefore, a
mild protection is not totally unexpected to be observed in the
results. However, the loss of protection strongly suggests that
the methylation of NAHIS02 is affecting at the site of the
molecule that interacts with the Ab channel.
DISCUSSION
The results described in this investigation show that His-
coordinating and His-related compounds can efﬁciently
block Ab channels incorporated into artiﬁcial membranes,
FIGURE 5 Protection of cells from Ab cyto-
toxicity by compounds that coordinate and as-
sociate with Ab channels. Viability of PC12S
cells (A and B), and cortical (C and D) and
hippocampal neurons (E and F) observed after
3 days of incubation in the presence of Ab
peptide (5 mM) and Ab peptide (5 mM) plus
Ni21, imidazole, or His. The results from the
XTT assay are expressed as a percentage of
cytotoxicity (A, C, and E). The LDH released
from cells into the media is expressed as a
percentage of protection of cells (B, D, and F).
Imidazole and Ni21 fully protect cells against
Ab cytotoxicity, but Ni21 showed a cell-depen-
dent toxicity at high concentrations. His per-
formed poorly in protecting cells from Ab
toxicity.
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and can also entirely prevent Ab cytotoxicity produced by
the incorporation of Ab channels in the cell surface mem-
brane. Therefore, we interpret these data to support the hy-
pothesis that His residues within the Ab channel sequence are
in the pathway of ion ﬂow and contribute to deﬁne the ion
channel selectivity. Additionally, the data conﬁrm the con-
tribution of the Ab channel to the cytotoxicity of Ab.
We previously reported that small peptides designed to
closely match the sequence of the Ab peptide that includes
His13 and His14 were the most effective at blocking ion
currents through Ab channels (35,36). The results of the
investigation presented here strongly suggest that Ab chan-
nel blockage by compounds of known His-coordinating ca-
pacity, such as Ni21 and imidazole, occurs by the interaction
with the His residues located in the pathway of the ions in the
Ab channel. This conclusion is supported by the enhanced
blocking efﬁciency observed after increasing the number of
imidazole reactive side chains in His-related compounds.
Additionally, we observed that perturbing the bonding of the
imidazole side chains by selective methylation, which pre-
vents the interplanar interaction of imidazole with the aro-
matic His residues, results in abolition of Ab channel current
activity and neurotoxicity.
Binding sites for the Ab channel blockers
The highly effective block of the Ab channels observed in our
experiments after the application of either nickel (Ni21) or
imidazole is expected if the His in the Ab subunits of the Ab
channels are the participating residues. Information collected
from the Protein Data Bank reveals that among the aromatic
residues His can be found in various chemical environments
FIGURE 6 Protection of cells from Ab cytotox-
icity by His-related compounds that establish aro-
matic interaction with Ab channels. Viability of
PC12 cells (A and B), and cortical (C and D) and
hippocampal neurons (E and F) observed after
3 days of incubation in the presence of Ab peptide
(5 mM) and Ab peptide (5 mM) plus NAHIS01,
NAHIS02, NAHIS02-(p-Met), and NAHIS04. The
results from the XTT assay are expressed as a
percentage of cytotoxicity (A, C, and E). The
LDH released from cells into the media is expressed
as a percentage of protection of cells (B, D, and F).
The level of protection for all these compounds
correlated to the number of reactive imidazole side
chains. NAHIS02 and NAHIS04 fully protected the
cells against Ab. NAHIS02-(p-Met) was very in-
efﬁcient at protecting against Ab peptide cytotox-
icity.
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in protein structures, sometimes behaving as an aromatic
residue, or as a metal ligand, and at other times forming salt
bridges with acidic groups (38). The interaction between His
and Ni21 is so profound that the His tag is globally the most
used tag in the preparative puriﬁcation of proteins. Immobi-
lized metal afﬁnity chromatography, which is used to purify
His-tagged proteins, exploits the ability of His to bind che-
lated transition metal ions, and Ni21 has generally been
proven to be the most successful of the metal ions. Compet-
itive interaction is the most common method used to recover
the puriﬁed protein fractions. Imidazole competitively inter-
acts with immobilized Ni21 ions to reverse the binding of the
protein. With the exception of nickel, the compounds that we
found in this investigation to be efﬁcient for blocking the Ab
channels were aromatic residues containing the hetero-
aromatic imidazole ring. As a heteroaromatic moiety, imid-
azole can interact with other aromatic and nonpolar groups,
since it can exist in the neutral or positively charged form at
the physiological pH. Additionally, imidazole can form the
most conspicuous hydrogen bonds with polar and charged
(both negative and positive) residues (39,40). Depending on
the protonation state, imidazole can also be involved in salt
bridges with acidic groups. For these reasons, it is expected
that effective interactions can be established between the
imidazole-containing compounds that blockAb channels and
the charged His6, His13, His14, Glu22, and Lys28 residues in
the Ab subunits in the Ab channel. However, among the
charged residues in the Ab subunit sequence, His is the only
aromatic residue and is the most likely candidate to carry the
preferred face-to-face geometric interactions with imidazole
(38). Imidazole is a ﬁve-membered planar ring that consists
of one p electron from the ¼N-atom, one from each carbon
atom, and two from theNH nitrogen. This resonance structure
makes imidazole an excellent nucleoﬁle that would be at-
tracted to a full or partial positively charged form of the His in
the Ab subunits of the Ab channels. Therefore, the propen-
sities of imidazole to interact with His residues vastly over-
come the propensities to interact with the other charged
residues, such as Lys or Glu, in the Ab subunit (38,40,41). In
the case of the His-related compounds tested for blocking the
Ab channel, we observed a remarkable increase in blocking
efﬁciency because the blocker compounds possess more avail-
able reactive imidazole side chains. In contrast, NAHIS02,
which behaved as a highly efﬁcient blocker, not only lost its
capacity to block the Ab channels, but additionally became
ineffective in protecting from Ab cytotoxicity when the imid-
azole side chains were perturbed by methylation. A large
number of studies have dealt with the subject of aromatic–ar-
omatic interaction in proteins. The vast majority of medicinal
agents contain aromatic substituents and their differential rec-
ognition by proteins is likely to be facilitated by the noncovalent
interactions involving aromatic residues (42). Among the aro-
matic residues, His has the highest propensity to interact with
planar groups and forms a distinct class separate from all other
residue types (40,41).
The function of the imidazole side chain in the
His interaction with the Ab ion channel
We observed that the efﬁcacy for blocking the Ab channel by
the amino acid His is improved when the free ends of His are
modiﬁed by amidation and acetylation of the carboxyl and
amine groups, respectively. This modiﬁcation, in addition to
making the peptide resistant to proteases degradation, re-
duces the peptide unspeciﬁc reactivity. Our interpretation of
the improved blocking efﬁcacy of NAHIS01 compared to the
ends-free His is that in the unmodiﬁed His, in addition to the
imidazole side chain, the free ends increase the possibility for
His to unspeciﬁcally interact with any other reactive residues
present in the Ab subunits of the Ab channel. Therefore, the
unspeciﬁc interactions with other regions of Ab reduce the
probability of speciﬁc interactions with His that form the ion-
conducting path of the Ab channel. When the His ends are
capped and are unable to chemically react, as is the case with
NAHIS01, the reactivity of His is restricted to the speciﬁc
interaction that may be established by its imidazole side
chain. Thus, the probability for aromatic interactions between
the exceptionally nucleoﬁlic imidazole in the ends-capped
His and the imidazole side chain in the participating His in
the Ab channel will be increased. We believe that the im-
proved efﬁcacy of the ends-capped NAHIS01 compared to
ends-free His, as an Ab channel blocker, is further proof of
the concept that the aromatic interaction between the imid-
azole side chains contributes to the blocking of Ab channels.
Blocking of Ab channels preserves cells from
Ab cytotoxicity
The efﬁcacy of His coordinating compounds for preserving
cells from Ab cytotoxicity was tested in three different types
of cells. Initially, the preservation of the viability of cells
observed in cases where speciﬁc Ab channel blockers were
used in combination with Ab conﬁrmed the participation of
the Ab channels in Ab cytotoxicity (9,36). Those compounds
that were observed to fully block Ab channels incorporated
into artiﬁcial membranes were also found to be efﬁcient at
preserving cell viability during exposure to the toxic Ab
peptide. The results were obtained from three different cell
types by the application of two different viability assays. It
has been shown that the interaction between Ab peptides and
the cell surface membrane is followed by activation of an
intracellular signaling cascade that leads to the death of cells
by apoptosis (43). The ﬁnding that Ab channel blockers fully
prevent cell death corroborates the formation of Ab ion
channels as the initial step in the changes associated with the
Ab-induced apoptosis (9), and suggests that channel forma-
tion is the main mechanism by which Ab exerts its toxicity.
Additionally, the data shown here conﬁrm that exposure of
cells to Ab results in the formation of oligomeric Ab ag-
gregates, which assemble the Ab channels as they interact
with the cell surface membrane. This is the ﬁrst step in the
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signaling cascade that leads to cell death. The results from the
application of viability assays on the three different types of
cells show that the efﬁcacy of the His-related compounds to
preserve cells from Ab cytotoxicity is correlated to the in-
tensity of the interactions with the His residues in the Ab
channel. By increasing the number of reactive imidazole side
chains in the blocker compound, the capacity to block the
active Ab channels incorporated into the membranes of the
cells is also increased. Our results in cultured cells showed
that the blocking efﬁcacy of His-related Ab channel blockers
was improved to EC50 values below the micromolar levels, as
was the case for the blockers NAHIS02 and NAHIS04. This
represents a considerable improvement compared to the block-
ing effect obtained with previously published Ab channel
blockers (16,35,36).
Our experimental results and the theoretical
models of the Ab channel
The channel-like annular structure of Ab oligomers, as has
been observed by electron microscopy (44) and by AFM
(23,24), suggests that to form an Ab channel, Ab subunits
assemble in a polymeric transmembrane structure. Based on
this structure, a series of theoretical models have been de-
signed to shape the different forms that oligomers of Ab as-
semble to form ion channels when incorporated into a lipid
membrane (25–27). The most recently developed models,
which illustrate the atomistic structure of the Ab channel in
annular topology, follow molecular-dynamics simulations
based on nuclear magnetic resonance data of the oligomers
and use the universal U-shaped (strand-turn-strand) motif for
the truncated Ab17–42 (26,27). Although these models do not
include the ﬁrst 16 residues of the Ab subunits, which contain
the His residues, the negatively charged side chains of Glu22
are arranged circularly in the pore, inducing a cationic ring by
the binding of cations such as Mg21, Ca21, K1, and Zn21
(26,27). Former models were developed based on least-en-
ergy calculations, and assume that the channels are formed
from an assembly of Ab subunits arranged symmetrically
around the axis of a pore lined by an amphipathic array of
alternated charged residues. In this case the resulting models
present rings of His13 and His14 residues of the Ab molecule
around the entrance of the putative pore (25). If not all the His
are protonated, this annular arrangement will model pores
with a net negative charge to explain the cation selectivity of
the Ab channels. The theoretical models for the truncated
Ab17–42 include the charged residues Glu22 and Lys28 of the
Ab subunit. The old model on energetic grounds for the full-
length Ab1–40 includes in addition the charged residues His6,
His13, and His14. Although the molecular-dynamics simula-
tions successfully reproduce the channel dimensions, shapes,
and subunit organization of the Ab channels observed with
AFM (23,24), our results from using His-containing Ab
channel blockers could be better explained by a model that
will represent the full-length Ab subunit. Such a model must
include His residues in addition to the Glu22 and Lys28
charged residues. There are examples of the amino end of the
Lys side chain and Glu acid side chain interacting with His
residues. However, His prefers to interact in a face-to-face
stacked orientation with His rings (38,40). We speculate that
this may provide stability to the assembly of Ab subunits in a
polymeric transmembrane channel structure. In this respect,
disruption of this His-His interaction may prevent the func-
tioning of Ab channels. Recent experiments showed that
perturbing the hydrogen bonding of the imidazole side chains
of His residues of Ab by selective methylation prevents the
formation of His bridges and results in abolition of the Ab
neurotoxicity (37).
In conclusion, the addition of compounds of known His-
coordinating capacity, such as Ni21, imidazole, His, and a
series of His-related compounds, to Ab channel incorporated
in membranes show that the His residues located in the
N-terminal branch of the Ab peptide sequence are essential to
form the functional structure that constitutes the selectivity
ﬁlter and the ion pathway of the Ab channel. To achieve the
functional characteristic of the Ab channels, the theoretical
models, constructed to shape the different forms that oligo-
mers of Ab assemble to form ion channels, have to include the
segment of the Ab peptide that contains the charged His
residues.
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